Prime Capital Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Prime Capital Investment Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,854	Closed	-$232K	–	1034
2025 Q1	$232K	Buy	+3,854	New	+$239K	﹤0.01%	924
2024 Q2	–	Sell	-4,714	Closed	-$276K	–	978
2024 Q1	$276K	Buy	4,714 +19	+0.4%	+$1.07K	﹤0.01%	799
2023 Q4	$253K	Buy	4,695 +112	+2%	+$5.47K	﹤0.01%	793
2023 Q3	$222K	Buy	4,583 +48	+1%	+$2.55K	﹤0.01%	658
2023 Q2	$256K	Buy	+4,535	New	+$250K	0.01%	649

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Prime Capital Investment Advisors's IHI Position: Q2 2025 in Review

Prime Capital Investment Advisors sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 3,854 shares — an estimated $232K sold.

Prime Capital Investment Advisors first reported a position in IHI in Q2 2023 and held it in 5 quarters. The position peaked at $276K in Q1 2024. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

Prime Capital Investment Advisors reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
Prime Capital Investment Advisors sold 3,854 iShares US Medical Devices ETF shares in Q2 2025, an estimated $232K.
Prime Capital Investment Advisors first reported a position in iShares US Medical Devices ETF in Q2 2023 and held it in 5 quarters.
Prime Capital Investment Advisors's iShares US Medical Devices ETF position peaked at $276K in Q1 2024.
546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.